Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Massachusetts General Hospital
Patients will undergo two weeks of prospective observation, they will then receive ketamine IV 0.5mg/kg over 45 minutes as augmentation of their ongoing antidepressant regimen; after three infusions this dose will be increased increase to 0.75 mg/kg in non-responders. The schedule of administration will be twice a week for 3 weeks. After this phase, the patient will be followed with assessments every two weeks for three months.
Total duration of the study is 5 months.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Outpatients with severe treatment-resistant MDD
Currently depressed
Currently under regular psychiatric care
On an aggressive antidepressant regimen, stable for 4 weeks
You may not be if
No history of other major psychiatric illnesses, including bipolar disorder
No history of psychosis
No history of drug abuse
No major medical illness or unstable medical conditions